Kidney transplantation
Conditions
Interventions
cyclosporinbasiliximab + steroids + mizoribine
Sponsors
MNKT Forum
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.living donor kidney transplantation. 2.Gender free, any case of uremia. 3.Aged 2 years to 70 years. 4.ABO compatible (including semi-compatible) The patient or whose family has submitted (if the patient is showing disturbance of consciousness or decreased ability to understand) written consent forms based on their free choice once adequate information and understandings are obtained regarding the study upon the participation.
Exclusion criteria
Exclusion criteria: 1.The patient who has a history of hypersensitivity against components of either one of the following drugs: Bredinin tablet, Neoral or Simulect. 2.The patient who is pregnant or a female patient who is expecting to become pregnant. 3.The patients who showed a positive result with cross match test. 4.The patient who recived ABO incompatible donor. 5.The patient with whom the physician-in-charge considered inappropriate as a subject of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of virus infection | — |
Secondary
| Measure | Time frame |
|---|---|
| Rejection reactions (incidence, types, severity), patient survival rate, graft suvival rate, incidence of adverse events / abnormalities in the laboratory values. | — |
Countries
Japan
Outcome results
None listed